Page last updated: 2024-08-17

adenosine diphosphate and Lymphoma, Mantle-Cell

adenosine diphosphate has been researched along with Lymphoma, Mantle-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burbury, K; Cole-Sinclair, M; Filshie, R; Horton, L; Kamel, S; Keating, MJ; Khot, A; Levade, M; Nandurkar, H; Reynolds, J; Sandhu, S; Schischka, S; Tam, CS; Tan, S; Ysebaert, L	1

Other Studies

1 other study(ies) available for adenosine diphosphate and Lymphoma, Mantle-Cell

Article	Year
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation. Leukemia, 2015, Volume: 29, Issue:4 Topics: Adenine; Adenosine Diphosphate; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Platelets; Cells, Cultured; Collagen; Female; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Platelet Aggregation; Pyrazoles; Pyrimidines; Severity of Illness Index	2015

Article

Year

Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.

Leukemia, 2015, Volume: 29, Issue:4

Topics: Adenine; Adenosine Diphosphate; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Platelets; Cells, Cultured; Collagen; Female; Hemorrhage; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Piperidines; Platelet Aggregation; Pyrazoles; Pyrimidines; Severity of Illness Index

2015